Cargando…
Parenteral–Oral Immunization with Plant-Derived HBcAg as a Potential Therapeutic Vaccine against Chronic Hepatitis B
Chronic hepatitis B (CHB) is the cause of severe liver damage, cirrhosis, and hepatocellular carcinoma for over 240 million people worldwide. Nowadays, several types of treatment are being investigated, including immunotherapy using hepatitis B core antigen (HBcAg) assembled into highly immunogenic...
Autores principales: | Pyrski, Marcin, Mieloch, Adam Aron, Plewiński, Adam, Basińska-Barczak, Aneta, Gryciuk, Aleksandra, Bociąg, Piotr, Murias, Marek, Rybka, Jakub Dalibor, Pniewski, Tomasz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6963566/ https://www.ncbi.nlm.nih.gov/pubmed/31835350 http://dx.doi.org/10.3390/vaccines7040211 |
Ejemplares similares
-
Assembly and Characterization of HBc Derived Virus-like Particles with Magnetic Core
por: Rybka, Jakub Dalibor, et al.
Publicado: (2019) -
Generation of fusion protein EGFRvIII-HBcAg and its anti-tumor effect in vivo
por: Duan, Xiao-yi, et al.
Publicado: (2009) -
Intranasal HBsAg/HBcAg-Containing Vaccine Induces Neutralizing Anti-HBs Production in Hepatitis B Vaccine Non-Responders
por: Shiraishi, Kana, et al.
Publicado: (2023) -
Incidencia de HBcAg en donadores de sangre hospital general de zona No. 32, Minatitlán, Ver.
por: Pérez García, Eduardo
Publicado: (1995) -
Studies on HBcAg-rBlo t 5-21 Fusion Protein Vaccine That Alleviates Blomia tropicalis Airway Inflammation
por: Pei, Yechun, et al.
Publicado: (2022)